Trial
NCT05116800
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Brown University
Collaborators
Actuate Therapeutics Inc.
Condition
Soft Tissue Sarcoma
Intervention
Gemcitabine
Why stopped
IND withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-07